Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021

Overcoming COVID-19 Investigators

Research output: Contribution to journalArticlepeer-review

78 Scopus citations
Original languageEnglish (US)
Pages (from-to)52-58
Number of pages7
JournalMorbidity and Mortality Weekly Report
Volume71
Issue number2
DOIs
StatePublished - Jan 14 2022

ASJC Scopus subject areas

  • Epidemiology
  • Health(social science)
  • Health, Toxicology and Mutagenesis
  • Health Information Management

Cite this